the Efficacy of Leucogen in Preventing the Risk of Ribociclib-Associated Neutropenia in Early Breast Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Leucogen · Ribociclib · Neutropenia (Low White Blood Cell Count) · Breast Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Breast surgery department, Hangzhou, Zhejiang, China
Contact: Study coordinator (Jing xin Jiang, Docotor) · 11418327@zju.edu.cn · 0571-89713716

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Randomized, Self-controlled Post-marketing Clinical Study on the Comparison of Shengbai Oral Liquid and Leucogen Tablets in the Treatment of Moderate Neutropenia Caused by Anti-tumor Drugs in Breast Cancer Patients

Breast Cancer · Bone Marrow Suppression

Abroad (travel likely)RecruitingPHASE4

Shanghai, China